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A direct bathophenanthroline method was adapted to the DSA 560 (Beckman Instruments) for the mechanized determination of the iron
concentration and of the total iron binding capacity in 300 μ\ serum. The reliability of this procedure and the experimental conditions for
the binding of Fe3+ ions were investigated. Between 100 and 500 ̂ mol/1 Fe3+ the "saturation curve of the total iron binding capacity
reached a plateau which approximately correlated with the immunological transferrin concentration. This plateau could not be observed
with some commercial control sera.
Eine direkte Bathophenanthrolin-Methode wurde an den DSA 560 (Beckman Instruments) zur mechanisierten Bestimmung der Eisen-
konzentration und der totalen Eisenbindungskapazit t in 300 μ\ Serum adaptiert. Die Zuverl ssigkeit dieses Verfahrens und die experi-
mentellen Bedingungen f r die Bindung von Fe3+-Ionen an Serumeiwei wurden untersucht. Die S ttigungskurve der totalen Eisen-
bindungskapazit t erreicht zwischen 100 und 500 /-tmol/l Fe3+ ein Plateau, das ungef hr mit der immunologischen Transferrin-Konzen-
tration korreliert. Dieses Plateau konnte bei einigen kommerziellen Kontrollseren nicht beobachtet werden.
In clinical chemistry the serum iron concentration is
usually determined by photometric procedures. A
direct bathophenanthroline method, which is available
as a commercial kit, was adapted to the Discrete Sample
Analyzer (DSA) 560, a combined-discrete system (1).
A report on the reliability of this mechanized procedure
is presented in the light of our experience in its operation.
Usually, the determination of the iron binding capacity
is requested parallel with that of the serum iron con-
centration. Therefore both methods should be mechan-
ized together. For the determination of iron binding
capacity all samples are prepared manually. After the
addition of FeCl3 to 200 μΐ serum the excess of ferric
ions is precipitated with MgCO3 according to RAMSAY
(2). The supernatant is introduced into the DSA 560
and analyzed for its total iron concentration.
Materials and Methods
Instruments
DSA 560: Beckman Instruments Inc. (USA, Fullerton 92634).
Photometer 1101 M, Dispenser 5210, Microcentrifuge 5411
(16000r. p.m.), Rotating Mixer 5431: Eppendorf Ger tebau
GmbH (D-2 Hamburg).
Materials
Merckotest No. 3307 and No. 3313 are purchased from E. Merck
AG (D-61 Darmstadt), iron wire from Riedel-de-Haen AG
(D-3016 Seelze), MgCO3 from J. T. Baker Chemicals N. V.
(NL-Deventer), bovine albumin (purest) from Behringwerke AG
P-355 Marburg), Seronorm from Dr. Molter GmbH (D-69
Heidelberg), Monitrol from Merz and Dade (D-8 Munich),
polypropylene reaction cups (Nr. 39/10 A) and monovettes for
blood sampling (Nr. 950 RA) from W. Sarstedt (D-5223 Niim-
brecht) and Q-cups (US-type, N*. 5206) from Beckman Instruments
Inc. (USA, Fullerton 92634).
Solutions
Solution 1—3 are taken from Merckotest No. 3307.
1. Colour reagent: 4,7-diphenyl-l,10-phenanthroline-disulfonic
acid (bathophenanthroline, disodium salt, 0.68 mmol/1) and sodium
phosphate buffer (0.4 mol/1, pH = 5.5).
2. Sodium phosphate buffer (0.4 mol/1, pH = 5.5).
3. Working-Standard (17.9 /*mol/l Fe8+).
4. Sodium ascorbate (part of Merckotest No. 3307):
800 mg sodium ascorbate + 20 ml H2O (must be prepared daily).
5. Stock binding reagent:
500 mg FeCl8 * 6 H2O (Merck No. 3943) + HC1 (0.1 mol/1,
Merck No. 9973) to 500 ml.
6. Binding reagent:
Stock binding reagent 5 ml + H2O to 100 ml.
7. Magnesium carbonate:
4 MgCO3 · Mg(OH)2 · nH2O (Baker No. 0161) 1.5 g + 5 ml
H2O (must be shaken before use). This sludge can be conveniently
transferred with Eppendorf micropipettes if the MgCO3 is purch-
ased from Baker.
8. Reference-standard (3):
a) Stock solution: a small piece (approx. 500 mg) of iron wire p. a.
(Riedel de Haen, No. 31243) is dried until constant weight and
added to 7 ml cone. HC1 (Merck No. 317) and 5 ml double distilled
H2O. The container is placed in a boiling water until the wire is
dissolved. The solution is then cooled to room temperature and
brought to 500 ml with double distilled H2O.
b) Working solution: 5ml stock solution + 500 ml HC1
(0.01 mol/1, Merck No. 9974) + double distilled H2O to 1000 ml.
9. Titrisol-standard:
a) Stock solution: content of 1 vial Titrisol Eisen-Standardl sung
(Merck No. 9972), 5 ml cone. HC1 (Merck No. 317) + double
distilled H2O to 1000 ml.
b) Working solution: 89.5 /*mol/l.
5 ml stock solution, 2 ml cone. HC1 (Merck No. 317) + double
distilled H20 to 1000 ml.
The iron concentration of the working solution determined at
10 days and referred to solution 8b was 89.49 μιηοΐ/ΐ (s = 1.35).
All further results were referred to the Titrisol-standard (9b)
which was used to check the Merckotest-standard.
All solutions are prepared with dcionized and quarz distilled water
(approx. 0.5 μ$). The glassware is washed in a standard machine,
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Flow diagram Scheme of the DSA 560 for the determination of the iron concentration
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Fig. 2
The sequence of samples introduced into the DSA 560 for the determination of the iron concentration. The intersegment B can be repeated
as often as required. A: the photometer is adjusted to give a zero printout
then soaked in concentrated HC1 and rinsed carefully with double
distilled H2O.
Preparation of samples for the determination of the
total iron binding capacity
Reaction cups are filled with Eppendorf micropipets:
Serum 200 μ\
Solution (6) 200 μΐ
Shake l min (Rotating mixer)
Let stand 5 min
Solution (7) 400 μΐ
Shake l min (Rotating mixer)
Let stand 30 min
Centrifuge 10 min
The supernatant is analyzed for its total iron concentration, the
result must be multiplied by 3.5 (dilution factor).
Each batch for the determination of iron binding capacity is
started by 1 or 2 samples in which water is substituted for serum
to check the adsorptive properties of MgCO8: iron should not
be detected in the supernatant of this blank assay.
The unbound iron binding capacity is determined according to
SCHADE et al. (4) using Merckotest No. 3313.
Determination of the iron concentration
The iron concentration was determined directly in serum samples
without deproteinization with the DSA 560 which is operated
according to the instructions of the manufacturer. The set up of the
analyzer is illustrated in Figure 1 and the sequence of samples in
Figure 2. Reagent blank values usually drift parallel to the standard
values and, therefore, need not be controlled separately. The
primary standard (17 //mol/1) drifted about + 0-7% between
20 samples (= 1 segment) at 27 days. Therefore, drift corrections
are not necessary. The photometer readings are printed out and
the final results are calculated using primary standards at the
beginning of each segment.
The manual determination of the iron concentration was per-
formed according to SCHWARTZ (6) in trichloracetic acid extracts
following the instructions of Merckotest No. 3307.
Transferrin was directly determined by a radial immunodiffusion
technique using Partigen plates (Behringwerke AG, D-355 Mar-
burg) according to MANCINI et al. (5).
For the determination of the precision 3 identical serum samples
(xa> Xb, Xc) are analyzed daily immediately following the standard
/ 100 - x \
solutions (Fig. 1): the precision within-series I CVS = )
+ Xci)
is calculated from thexb— andxc values l x 2m
2m
> — (or the xc) values
I, the precision from-day-to-day from the
; s =
Tab. 1









Behring*), (Lot-No. 107 A)
Standard solution
Standard solution + albumin (70 g/1)
Pooled human serum
Asid*), (Lot-No. OPJ401)
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Results and Discussion
Determination of the iron concentration
The direct bathophenanthroline method of SCHWARTZ
(6) was adapted to the DSA 560 and found precise
enough for clinical routine determinations of the iron
concentration in serum samples (Tab. 1). It correlated
well with the manual procedure (Fig. 3) and was linear
up to 200 ̂ mol/1 Fe3+ (Fig. 4). Different iron concen-
trations added to various human serum and urine
samples were recovered within the ± 1% range (Tab. 2).
Interaction effects
Interaction effects are possible either at the sample
pick up station or in the flow-through cuvet of the
DSA 560. The first type of carry over could not be
detected if a protein-containing sample (1) with
100 //mol/1 iron was followed by a second one (2) with
a pure albumin solution (Tab. 3). To discriminate
between cross-contamination1) and carry-over effects
60 h
Tab. 2
Recovery of Fea+ added to various human sera and urine samples
20 30 40 50
Fe3MOSA 560)[ / imol / l ]
60
Fig. 3
Correlation between a manual and the mechanized procedure for the





Fe 3 + [ j jLmol/ l ]
Fig. 4
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*) mean values from 2 determinations
Tab. 3
Cross-contamination between samples. Several Technicon cups
(No. 127—0018) were filled with 1ml double distilled HaO (A) or
albumin solution (B, 70 g/I), No. 1 contained FeCl3 (100 ^mol/I) in
addition. The pick-up tube dipped into the sample until it almost
























































For explanation of the nomenclature see (1).
which occur in the flow-through-cuvet system, sample
(2) must be reanalyzed in segment of blank samples
containing no iron ions (Tab. 3).
A prerinsing concept with air bubbles segmenting the
stream of the reaction mixture minimizes the interaction
effects in the flow-through system of the DSA 560
photometer. The percent coefficient of interaction
determined according to HJELM (7) was 1.4% for Q±
and (V).
This value has to be considered in relation to the
precision of the method. In a previous communication
(8) we postulated that the error due to interaction
effects should be less than the twofold or threefold
value of the standard deviation determined in a batch
with samples containing various concentrations of iron.
From the figures in Table 1 and the Q value reported
above a range can be calculated by means of equations
derived recently (8), in which carry-over effects can
be neglected (Fig. 5). It is assumed that Q is independent
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The "interaction-safe range" (7) of the iron determination with the
DSA 560. The concentrations forming this range are calculated
according to (7): C1(i for the interaction from low to high concentrationsan C,,! for the interaction from high to low concentrations. The stan-
dard deviations are taken from Table 1. Qt « 1.36 rb 0.53 (n = 20),Q2 = 1.39 ± 0.58 (n = 20). It is postulated that the error due tocarry-over effects should be lower than the threefold (resp. twofold =
dotted line) value of the within-series precision (standard deviation).
TIBC = Total iron binding capacity
of the concentration difference between samples follow-
ing each other as we have already shown for other
procedures (8).
Figure 5 demonstrates that serious errors due to inter-
action effects are not be to expected with normal human
sera. If a sample containing more than 40 ̂ mol/1 Fe3+
is followed by a second one with 5 ̂ mol/1 Fe3* or less,
the analysis of the last one has to be repeated because
the error due to interaction effects exceeds the postulated
limit of 3 standard deviations (Fig. 5).
Determination of the iron concentration in
urine samples
According to several authors (9, 10) the direct batho-
phenanthroline method can also be used for urine
samples. However, only elevated excretions of iron ions
can be measured by this procedure, because the detection
limit is about 0.3 ̂ mol/1 (n = 28 days) as determined
according to KAISER (11). The mean normal iron
concentration of human urine is about 0.8 μηιοΐ/ΐ (12).
Interference
GOODWIN et al. (13) investigated the effect of lipemia,
bilirubin and chelating agents as EDTA, DTPA
(diethylenetriaminepentaacetic acid) and desferrioxa-
mine without detecting any significant interference with
the bathophenanthroline method. However, hemo-
globin (13) and Cu2+ ions (10) elevate the results
erroneously. The iron concentration of a standard
with 17 μηιοΐ/ΐ Fe3+ was found approximately 50% too
high if the solution contained 90 μπιοΐ/l Cu2+ ions.
Iron binding capacity
The various methods mainly used for the determination
of the serum transferrin concentration may be divided
into 2 groups:
1. direct procedures using immunoprecipitation tech-
niques (5, 14), and
2. indirect methods which measure the amount of
iron bound to transferrin under saturating conditions
(iron binding capacity). It is well known that 1 mole
transferrin binds 2 moles Fe3+. These methods anti-
cipate that all exogenous iron is bound exclusively to
transferrin. Two ways are possible:
a) RAMSAY (2) precipitates the excess of iron with
MgCO3 and determines all iron bound by the serum
sample (total iron binding capacity). The free or
unbound iron binding capacity is calculated by sub-
tracting the iron concentration from the total iron
binding capacity.
b) Conversely, the unbound iron binding capacity can
also be measured directly either by colorimetric methods
(4, 15) or by radiological procedures (16—18).
Both procedures are compared with a direct immuno-
logical determination of transferrin (Fig. 6) using
various human serum samples. In contrast to RENTSCH
(19) the average value of the unbound iron binding
capacity method was 10% lower than the mean trans-
ferrin-iron value indicating that the binding capacity
was not fully saturated under these experimental
conditions. With the total iron binding capacity proce-
dure of RAMSAY we observed the highest mean vlaue
for the iron binding capacity in agreement with several
authors (20—22), which have shown that besides
transferrin other plasma proteins are able to bind iron
ions. Therefore, the iron binding capacity value must
be expected to exceed the transferrin-iron concentration
in human sera. Indirect methods which yield iron
binding capacity values lower than those determined
with immunological procedures should be rejected.
Following these considerations we have chosen the
method of RAMSAY, adapted it to the Eppendorf micro-
liter system and the DSA 560 and reexamined the ex-
perimental conditions.
The value of the iron binding capacity increases with
rising iron concentration (Fig. 7). This saturation curve
is characterized by 2 points: a sharp bent at 50 μτηοΐβ
Fe3+ (assay concentration before the addition of MgCO3)
and an upward bent at higher concentrations. The
location of the second bent varied between 150 and
SOO^mol/1. Between both points a plateau is usually
reached which is more or less flat. The first bent is
presumably caused by the saturation of transferrin
with iron, which is probably completed at a Fe3+
concentration of 90μηιο1/1. According to the curves
shown in Figure 7 human serum samples should not be
incubated with Fe3+ concentrations less than 50 or
Z. Klin. Chem. Klin. Biochem. / 11. Jahrg. 1973 / Heft 7
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Fig. 6
Correlation between a direct immunological and an indirect colorimetric determination of the iron binding capacity, a) Unbound iron
binding'capacity (manual procedure), y = 0.8975x— 0.0873, r = 0.99 (m = 120). b) Total iron binding capacity (DSA 560), y = 1.1110 χ +
0.4692, r = 0.99 (m = 140). In both cases, r differs significantly from zero (P < 0.001)
MgCO3 we prefer to wait 30min (Tab. 4) until the
samples are centrifuged, in agreement with GOODWIN
et al. (13).
However, this incubation time appears not to be
critical (Tab. 4). The addition of sodium b rbital as
suggested by WILLIAMS and CONRAD (23) is not
necessary, since serum has enough buffering capacity
to guarantee an alkaline pH.
Enough MgCO3 (120 mg/assay) is added as determined
from Figure 8. When MgCO3 was formed from Mg2+
and COf~ ions as proposed by FRIED and HOEFLMAYR
(24) the saturation point cannot clearly be defined with
pooled human serum (Fig. 9).
Under these experimental conditions the from-day-to-
day precision of the determination of total iron binding
capacity with the DSA 560 was 2.8% (Tab. 1).
In conclusion, the mechanized procedure for the
measurement of iron binding capacity as reported
above is reliable enough for clinical purposes. In
agreement with SCURO et al. (21) the author suggests








of the Fe3+ concentration (200 μ\ serum -f- 200 μ\
on the total iron binding capacity of six human sera
more than 100 ̂ mol/1. If the serum was substituted by
double distilled H2O even a concentration of 1000 μτηοΐ/ΐ
Fe3+ was competely absorbed. Control sera which must
be reconstituted have different patterns of the saturation
curve as will be demonstrated in a following report.
An incubation time of 5 min is found sufficient for the
binding of FeCl3 to transferrin. After the addition of
Tab. 4
The influence of the incubation time (between addition of MgCO»
and centrifugation) on the adsorptive power of MgCOa. The figures
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The relationship between the total iron binding capacity of pooled
human serum and the_ MgCO, concentration used to precipitate the
unbound Fe»+ ions: 200 μ\ pooled serum, 200 al FeCl. (4.8 mg/1),
600 μ\ MgCO, suspension
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Fig. 9
The influence of the Mg*+ concentration on the total iron binding
capacity if free Fe3+ ions are bound by MgCO, in statu nascendi
Assay conditions: Ο Ο 200 μ\ pooled serum, 400 μ\ MgCla ·6 HaO + FeCla · 6 HSO (24,2 mg/1), 200 μ\ Na8COs (water free,200 g/l); χ - - - χ, O- - - Ο 200 μ\ pooled serum, 400 μ\
MgSO« · 7 HaO + FeCl, · 6 HaO (48 mg/1), 200 μ\ Na.CO, · 10 H2OThe conditions of incubation, centrifugation and determination of the
iron concentration in the supernatant with the DSA 560 are the same
as reported under methods
binding capacity and total iron-binding capactiy.
The discrepancy between both values "as an index of
extra-transferrin iron transport" (21) has to be further
evaluated with respect to its clinical significance. The
total iron binding capacity is a very relative term which
can be used only under the conditions represented by
the "plateau part" of the saturation curve (Fig. 7).
Various authors (25, 26) reported that storage of serum
leads to higher iron values with the direct bathophenan-
throline method. Under our experimental conditions
Tab. 5
The influence of storage (4°C) on the iron concentration (μπιοΐ/ΐ) and
the total iron binding capacity 0/mol/l) of various human sera. Each
value is a mean of 2 determinations
Storage, days 0 1 2 3 4







































































































































the iron concentration and the total iron binding
capacity (Tab. 5) of human sera did not change for at
least 3 days if the samples were kept at 4°C.
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